Corrigendum to "Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis" [Med. Hypotheses 129 (2019) 1-6]

Perumal K 1 , Kit Huin W 2 , Yi Yap N 1 , Aik Ong T 1 , Carolyn Gobe G 3 , Rajandram R 4

Affiliations 

  • 1 Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 3 Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Centre for Kidney Disease Research and School of Biomedical Sciences, University of Queensland, Australia
  • 4 Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Centre for Kidney Disease Research and School of Biomedical Sciences, University of Queensland, Australia. Electronic address: rretnagowri@gmail.com
Med Hypotheses, 2019 Oct;131:109284.
PMID: 31443767 DOI: 10.1016/j.mehy.2019.109284

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications